FFCP PHASE1:Hg19::chr7:138310867..138310878,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=136306 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=27034 | |||
|TSSclassifier=weak | |||
|UniProt= | |||
|association_with_transcript=-28bp_to_ENST00000478865_5end | |||
|coexpression_cluster_id=C64 | |||
|description=CAGE_peak_3_at_SVOPL_5end | |||
|id=chr7:138310867..138310878,- | |||
|ontology_enrichment_celltype=CL:0002274!6.58e-34!5;CL:0000457!6.58e-34!5;CL:0002191!6.58e-34!5;CL:0000097!6.58e-34!5;CL:0000831!6.58e-34!5;CL:0002028!6.58e-34!5;CL:0000163!8.84e-19!9;CL:0000037!1.23e-12!172;CL:0000566!1.23e-12!172;CL:0002032!7.07e-12!165;CL:0000837!7.07e-12!165;CL:0000763!8.38e-12!112;CL:0000049!8.38e-12!112;CL:0000988!1.03e-11!182;CL:0001024!4.99e-08!1 | |||
|ontology_enrichment_celltype_v019=CL:0000097;7.00e-64;5!CL:0000163;8.74e-36;9!CL:0000037;5.71e-21;1!CL:0001024;5.71e-21;1!CL:0000151;5.73e-09;36 | |||
|ontology_enrichment_celltype_v019_2=CL:0000097,7.01e-64,5;CL:0002028,7.01e-64,5;CL:0000163,8.75e-36,9;CL:0001024,9.43e-21,1;CL:0000763,2.56e-11,108;CL:0000049,2.56e-11,108;CL:0000037,2.70e-11,168;CL:0000988,1.07e-10,177;CL:0002032,1.64e-09,161;CL:0000837,1.64e-09,161;CL:0000151,2.87e-09,36 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:8692!1.03e-23!31;DOID:1240!4.00e-22!39;DOID:2531!2.22e-16!51;DOID:0060083!2.22e-16!51;DOID:9119!3.55e-08!1;DOID:1036!6.34e-08!8;DOID:8552!7.45e-08!1 | |||
|ontology_enrichment_disease_v019=DOID:9119;5.71e-21;1!DOID:8692;1.94e-10;31!DOID:1240;7.26e-10;39!DOID:2531;1.11e-08;51!DOID:0060083;1.11e-08;51 | |||
|ontology_enrichment_disease_v019_2=DOID:9119,3.45e-21,1;DOID:1240,8.05e-13,39;DOID:8692,1.48e-10,31;DOID:2531,7.83e-10,51;DOID:0060083,7.83e-10,51 | |||
|ontology_enrichment_uberon=UBERON:0002022!1.87e-07!1;UBERON:0002370!3.23e-07!4;UBERON:0005058!3.23e-07!4;UBERON:0009113!3.23e-07!4;UBERON:0003295!3.23e-07!4;UBERON:0005562!3.23e-07!4 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.17440175733939,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.263384084775077,0,0,0,0,0,0,0,0,0,0,0,0,0,0.493313713811028,0,0,0,0,0,0,0,0,0,0,0,0,0.150575119077773,0,0,0.236777252044017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.116193942869518,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.3165809473986,11.7104417237591,0.829312462163088,2.01767934783746,1.8936365013957,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.128343036279748,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.07254154547469,0.997896857164083,0.766021480529467,0,1.29848776109822,0.561594356226918,0,0,0,0.50787533340481,0,0,0,0,0,0,0,0,0,0,0,1.99843180798692,1.4098700508785,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0769502585037971,0,0,0,0,0,0,0,0,0.470940769185074,0.498635045700469,0,0,0,0,1.90723894776454,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0607495566580247,0,0,0.0524545881349981,0,0,0,0,0,0,0,0,0,0,0.410462603746695,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.078493092850514,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0918948995348449,0,0,0,0,0,0,0,0.129177819672012,0.124149428591716,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p3@SVOPL | |||
}} |
Revision as of 19:34, 22 January 2014
Short description: | p3@SVOPL |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_3_at_SVOPL_5end |
Coexpression cluster: | C64_Mast_chronic_acute_immature_chorionic_Basophils_Dendritic |
Association with transcript: | -28bp_to_ENST00000478865_5end |
EntrezGene: | SVOPL |
HGNC: | 27034 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
mast cell | 7.01e-64 | 5 |
basophil mast progenitor cell | 7.01e-64 | 5 |
endocrine cell | 8.75e-36 | 9 |
CD34-positive, CD38-negative hematopoietic stem cell | 9.43e-21 | 1 |
myeloid cell | 2.56e-11 | 108 |
common myeloid progenitor | 2.56e-11 | 108 |
hematopoietic stem cell | 2.70e-11 | 168 |
hematopoietic cell | 1.07e-10 | 177 |
hematopoietic oligopotent progenitor cell | 1.64e-09 | 161 |
hematopoietic multipotent progenitor cell | 1.64e-09 | 161 |
secretory cell | 2.87e-09 | 36 |
Ontology term | p-value | n |
---|---|---|
acute myeloid leukemia | 3.45e-21 | 1 |
leukemia | 8.05e-13 | 39 |
myeloid leukemia | 1.48e-10 | 31 |
hematologic cancer | 7.83e-10 | 51 |
immune system cancer | 7.83e-10 | 51 |